Basilea Pharmaceutica AG

USPTO Trademark & Patent Filings

Trademark applications and grants for Basilea Pharmaceutica Ag. Basilea Pharmaceutica Ag has 41 trademark applications. The latest application filed is for "MABELIO"

Company Profile

Basilea Pharmaceutica AG
ag pharmaceutica basilea
Basilea Pharmaceutica AG -
Basilea Pharmaceutica AG - Basel CH

State Incorporated	SWITZERLAND
Entity Type	aktiengesellschaft
Address	Grenzacherstrasse 487 Basel SWITZERLAND 4058

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents

Patent Applications

Patent Application	Date
PROCESS FOR THE MANUFACTURE OF ISAVUCONAZOLE OR RAVUCONAZOLE 20190077771 - 15/700647 Van Summeren; Ruben ; et al.	2019-03-14
USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE 20190010536 - 15/992813 Lane; Heidi Alexandra ; et al.	2019-01-10
USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES 20180364254 - 15/986577 Lane; Heidi Alexandra ; et al.	2018-12-20
SELECTED MACROLIDES WITH PDE4-INHIBITING ACTIVITY 20170327525 - 15/667894 Kellenberger; Johannes Laurenz ; et al.	2017-11-16
USE OF ACETYLATED TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES 20170122934 - 15/294157 Lane; Heidi Alexandra ; et al.	2017-05-04
Use of phospho-Akt as a biomarker of drug response 10,724,072 - 15/992,813 Lane , et al.	2020-07-28
Use of phospho-Akt as a biomarker of drug response 10,724,072 - 15/992,813 Lane , et al.	2020-07-28
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles 10,656,162 - 15/986,577 Lane , et al.	2020-05-19
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles 10,656,162 - 15/986,577 Lane , et al.	2020-05-19
Process for the manufacture of isavuconazole or ravuconazole 10,590,092 - 15/700,647 Van Summeren , et al.	2020-03-17

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"MABELIO" 98112480	MABELIO 2023-08-01
"BASILEA LABORATORIES" 97578739	BASILEA LABORATORIES 2022-09-05
"BASILEA LABS" 97578736	BASILEA LABS 2022-09-05
"BASILEA PHARMACEUTICALS" 97540286	BASILEA PHARMACEUTICALS 2022-08-08
"ADALUZIS" 90849710	ADALUZIS 2021-07-27
"MABELIO" 90849687	MABELIO 2021-07-27
"DATIROS" 90351478	DATIROS 2020-12-01
"ADALUZIS" 88809725	ADALUZIS 2020-02-25
"MABELIO" 88715051	MABELIO 2019-12-04
"BASILEA" 88633518	BASILEA 2019-09-27
"BASILEA PHARMACEUTICALS" 88319141	BASILEA PHARMACEUTICALS 2019-02-27
"BASILEA LABORATORIES" 88056375	BASILEA LABORATORIES 2018-07-27
"BASILEA LABS" 88056364	BASILEA LABS 2018-07-27
"MABELIO" 87479040	MABELIO 2017-06-07
"DATIROS" 87479061	DATIROS 2017-06-07
"BASILEA" 86984410	BASILEA 2016-03-10
"BASILEA" 86936140	BASILEA 2016-03-10
"BASILEA PHARMACEUTICALS" 86761593	BASILEA PHARMACEUTICALS 2015-09-18
"BASILEA LABS" 86504537	BASILEA LABS 2015-01-15
"BASILEA LABORATORIES" 86504577	BASILEA LABORATORIES 2015-01-15
"DATIROS" 86098423	DATIROS 2013-10-22
"MABELIO" 86098353	MABELIO 2013-10-22
"KETARIZO" 86098376	KETARIZO 2013-10-22
"IZERVA" 86098398	IZERVA 2013-10-22
"VLUISSE" 4523826 79128291	VLUISSE 2013-03-13
"ADALUZIS" 4523828 79128305	ADALUZIS 2013-03-13
"KAREEJ" 4519684 79128350	KAREEJ 2013-03-13
"ANTICIPA" 4523838 79128776	ANTICIPA 2013-03-13
"BASILEA PHARMACEUTICA" 85527461	BASILEA PHARMACEUTICA 2012-01-27
"BASILEA LABS" 85340883	BASILEA LABS 2011-06-08
"BASILEA LABORATORIES" 85340889	BASILEA LABORATORIES 2011-06-08
"BASILEA PHARMACEUTICALS" 3602748 79052210	BASILEA PHARMACEUTICALS 2008-02-07
"BASILEA" 3689485 79050107	BASILEA 2007-12-27
"BASILEA LABORATORIES" 77141293	BASILEA LABORATORIES 2007-03-27
"BASILEA LABS" 77139962	BASILEA LABS 2007-03-26
"BASILEA PHARMACEUTICA" 77042394	BASILEA PHARMACEUTICA 2006-11-13
"KETARIZO" 3318501 79024306	KETARIZO 2006-05-05
"MABELIO" 3318503 79024308	MABELIO 2006-05-05
"IZERVA" 3318504 79024309	IZERVA 2006-05-05
"DATIROS" 3318506 79024311	DATIROS 2006-05-05
"BASILEA PHARMACEUTICA" 76181144	BASILEA PHARMACEUTICA 2000-12-14

Company Registrations

NCAGE Code	SAKT4	BASILEA PHARMACEUTICA AG
CAGE Code	SAKT4	BASILEA PHARMACEUTICA AG

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.